Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Mealey RH, Stone DM, Hines MT, Alperin DC, Littke MH, Leib SR, Leach SE, Hines SA.

Vaccine. 2007 Oct 23;25(43):7582-97.

2.

Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.

Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, Hines SA.

Vaccine. 2003 Sep 8;21(25-26):3815-25.

PMID:
12922115
3.

Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.

Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC.

Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048.

4.

Cytotoxic T lymphocytes in protection against equine infectious anemia virus.

McGuire TC, Fraser DG, Mealey RH.

Anim Health Res Rev. 2004 Dec;5(2):271-6. Review.

PMID:
15984338
5.

Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.

Haghighi HR, Prescott JF.

Vet Immunol Immunopathol. 2005 Apr 8;104(3-4):215-25.

PMID:
15734542
6.

Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.

Vanniasinkam T, Barton MD, Heuzenroeder MW.

Int J Med Microbiol. 2005 Jan;294(7):437-45.

PMID:
15715172
7.

A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Yang K, Zhou J, Shen R, Zhang X, Shao Y.

Viral Immunol. 2012 Dec;25(6):477-84. doi: 10.1089/vim.2012.0014.

9.
10.

Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.

Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2007 Apr;88(Pt 4):1324-36.

PMID:
17374779
11.

Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.

Patton KM, McGuire TC, Hines MT, Mealey RH, Hines SA.

Infect Immun. 2005 Apr;73(4):2083-93.

12.

An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.

Lin YZ, Shen RX, Zhu ZY, Deng XL, Cao XZ, Wang XF, Ma J, Jiang CG, Zhao LP, Lv XL, Shao YM, Zhou JH.

Antiviral Res. 2011 Nov;92(2):292-304. doi: 10.1016/j.antiviral.2011.08.016.

PMID:
21893100
13.

Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.

Phumoonna T, Barton MD, Vanniasinkam T, Heuzenroeder MW.

Vaccine. 2008 May 12;26(20):2457-65. doi: 10.1016/j.vaccine.2008.03.015.

PMID:
18423949
14.
15.

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.

Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.

Vet Immunol Immunopathol. 2005 May 1;105(1-2):47-57.

PMID:
15797474
17.

Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Jacks S, Giguère S, Crawford PC, Castleman WL.

Clin Vaccine Immunol. 2007 Jun;14(6):669-77.

18.

VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.

Sanz MG, Villarino N, Ferreira-Oliveira A, Horohov DW.

Vet Immunol Immunopathol. 2015 Mar 15;164(1-2):10-5. doi: 10.1016/j.vetimm.2015.01.004.

PMID:
25681111
19.

Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.

Sanz MG, Oliveira AF, Loynachan A, Page A, Svansson V, Giguère S, Horohov DW.

Equine Vet J. 2016 Jan;48(1):103-8. doi: 10.1111/evj.12363.

PMID:
25257622
20.

Supplemental Content

Support Center